Ayalon Insurance Company’s AbbVie ABBV Stock Holding History

Ayalon Insurance Company’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-7,500	Closed	-$814K	–	163
2021 Q1	$814K	Sell	7,500 -970	-11%	-$104K	0.32%	68
2020 Q4	$908K	Hold	8,470	–	–	0.41%	59
2020 Q3	$732K	Hold	8,470	–	–	0.4%	54
2020 Q2	$840K	Buy	+8,470	New	+$746K	0.49%	51
2015 Q2	–	Sell	-149	Closed	-$9K	–	156
2015 Q1	$9K	Buy	+149	New	+$9K	0.01%	153

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Ayalon Insurance Company's ABBV Position: Q2 2021 in Review

Ayalon Insurance Company sold out of AbbVie (ABBV) in Q2 2021, closing a stake of 7,500 shares — an estimated $814K sold.

Ayalon Insurance Company first reported a position in ABBV in Q1 2015 and held it in 5 quarters. The position peaked at $908K in Q4 2020. 2,676 funds tracked by Wall St. Rank hold ABBV as of Q2 2021.

Ayalon Insurance Company reported no remaining AbbVie position as of Q2 2021 after selling out during the quarter.
Ayalon Insurance Company sold 7,500 AbbVie shares in Q2 2021, an estimated $814K.
Ayalon Insurance Company first reported a position in AbbVie in Q1 2015 and held it in 5 quarters.
Ayalon Insurance Company's AbbVie position peaked at $908K in Q4 2020.
2,676 funds tracked by Wall St. Rank held AbbVie as of Q2 2021.

Based on Ayalon Insurance Company's 13F filing for Q2 2021, filed 26 Jul 2021.